A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease

According to the current clinical practice guidelines for chronic obstructive pulmonary disease (COPD), the addition of inhaled corticosteroids (ICS) to long-acting β(2) agonist therapy is recommended in patients with moderate-to-severe disease and an increased risk of exacerbations. However, ICS ar...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Respir Res
Asıl Yazarlar: Miravitlles, Marc, Cosío, Borja G., Arnedillo, Aurelio, Calle, Myriam, Alcázar-Navarrete, Bernardino, González, Cruz, Esteban, Cristóbal, Trigueros, Juan Antonio, Rodríguez González-Moro, José Miguel, Quintano Jiménez, José Antonio, Baloira, Adolfo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2017
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5706374/
https://ncbi.nlm.nih.gov/pubmed/29183382
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-017-0682-y
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller